“…To our knowledge, this is the first meta-analysis of randomized clinical trials to assess the safety and immunogenicity of the 13-valent pneumococcal conjugate vaccine versus the 7-valent pneumococcal conjugate vaccine in infants. Previous studies [34][35][36] have evaluated another conjugate vaccine (7, 9, 11-valent) and recorded outcomes of IPD, otitis, or pneumonia [37][38][39]. Other reviews compared different 13-valent pneumococcal conjugate vaccine schedules in infants [40,41], or were not systematic reviews [10,42,43].…”